Literature DB >> 9159541

Use of the short form 36 (SF36) for health status measurement in rheumatoid arthritis.

J Talamo1, A Frater, S Gallivan, A Young.   

Abstract

The patient-administered Health Assessment Questionnaire (HAQ) is widely used in rheumatology studies. Another health quality assessment technique commonly used for other non-rheumatological conditions is the 'Short Form 36' (SF36). This has questions designed to assess eight aspects of health ranging from physical limitations to general perceptions of vitality and mental well-being. This study presents information on the health status of 137 patients with rheumatoid arthritis (RA) assessed by both the SF36 and HAQ. Summary statistics are given for the elements of the SF36 according to age, gender, disease measures of RA and the presence of co-morbidity. There were significant associations between the physical functioning score of the SF36 and the HAQ score. with other measures of disease activity and severity, and with co-morbidity, although there was considerable inter-patient variability. These findings suggest that future applications of health status questionnaires are possible.

Entities:  

Mesh:

Year:  1997        PMID: 9159541     DOI: 10.1093/rheumatology/36.4.463

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  28 in total

1.  The evaluation of quality of life in fibromyalgia syndrome: a comparison with rheumatoid arthritis by using SF-36 Health Survey.

Authors:  Murat Birtane; Kaan Uzunca; Nurettin Taştekin; Hakan Tuna
Journal:  Clin Rheumatol       Date:  2006-08-02       Impact factor: 2.980

2.  A pragmatic observational feasibility study on integrated treatment for musculoskeletal disorders: Design and protocol.

Authors:  Xiao-yang Hu; John Hughes; Peter Fisher; Ava Lorenc; Rachel Purtell; A-La Park; Nicola Robinson
Journal:  Chin J Integr Med       Date:  2013-12-13       Impact factor: 1.978

3.  Benchmarking: the five year outcome of rheumatoid arthritis assessed using a pain score, the Health Assessment Questionnaire, and the Short Form-36 (SF-36) in a community and a clinic based sample.

Authors:  N J Wiles; D G Scott; E M Barrett; P Merry; E Arie; K Gaffney; A J Silman; D P Symmons
Journal:  Ann Rheum Dis       Date:  2001-10       Impact factor: 19.103

4.  Impact of pregnancy on health related quality of life evaluated prospectively in pregnant women with rheumatic diseases by the SF-36 health survey.

Authors:  F Förger; M Østensen; A Schumacher; P M Villiger
Journal:  Ann Rheum Dis       Date:  2005-03-18       Impact factor: 19.103

5.  MRI of the wrist in early rheumatoid arthritis can be used to predict functional outcome at 6 years.

Authors:  N Benton; N Stewart; J Crabbe; E Robinson; S Yeoman; F M McQueen
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

6.  Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study.

Authors:  Zurab Nadareishvili; Kaleb Michaud; John M Hallenbeck; Frederick Wolfe
Journal:  Arthritis Rheum       Date:  2008-08-15

7.  Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis.

Authors:  Jacques Pouchot; Raheem B Kherani; Rollin Brant; Diane Lacaille; Allen J Lehman; Stephanie Ensworth; Jacek Kopec; John M Esdaile; Matthew H Liang
Journal:  J Clin Epidemiol       Date:  2008-03-21       Impact factor: 6.437

8.  Rituximab therapy for primary Sjögren's syndrome: an open-label clinical trial and mechanistic analysis.

Authors:  E William St Clair; Marc C Levesque; Eline T Luning Prak; Frederick B Vivino; Chacko J Alappatt; Meagan E Spychala; Josiah Wedgwood; James McNamara; Kathy L Moser Sivils; Lytia Fisher; Philip Cohen
Journal:  Arthritis Rheum       Date:  2013-04

9.  Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study.

Authors:  H S J Picavet; N Hoeymans
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

10.  Health-related quality of life in rheumatoid arthritis in Northern Sweden: a comparison between patients with early RA, patients with medium-term disease and controls, using SF-36.

Authors:  Elisabet West; Solveig Wållberg Jonsson
Journal:  Clin Rheumatol       Date:  2004-08-31       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.